28424445|t|Management of tachyarrhythmia during pregnancy
28424445|a|Maternal tachyarrhythmia is a common complication during pregnancy due to hormonal changes that enhance pre-existing arrhythmias or induce new arrhythmias in the presence of congenital heart defects in pregnant females. Presence of tachyarrhythmia during pregnancy poses risk to the mother and fetus, calling for proper treatment with medications. Use of antiarrhythmic drugs in cases of maternal tachyarrhythmia must give due consideration of potential teratogenic side effects. Utilization of antiarrhythmic drugs during pregnancy has been well studied; some result in minimal fetal harm or none at all. New techniques, such as cardiac ablation, have also been implemented with minimal or no radiation exposure to the fetus or mother. Pregnant women with tachyarrhythmia have been successfully treated with little to no impact on the developing fetus as result of increasing experience with antiarrhythmic drugs and progress of new procedural techniques.
28424445	0	10	Management	T057	C1273870
28424445	14	29	tachyarrhythmia	T033	C0080203
28424445	37	46	pregnancy	T040	C0032961
28424445	47	55	Maternal	T033	C1858460
28424445	56	71	tachyarrhythmia	T033	C0080203
28424445	77	83	common	T081	C0205214
28424445	84	96	complication	T046	C0009566
28424445	104	113	pregnancy	T040	C0032961
28424445	121	137	hormonal changes	T033	C1134488
28424445	143	150	enhance	T052	C2349975
28424445	151	163	pre-existing	T080	C2347662
28424445	164	175	arrhythmias	T033	C0080203
28424445	179	185	induce	T169	C0205263
28424445	190	201	arrhythmias	T033	C0080203
28424445	209	217	presence	T033	C0150312
28424445	221	245	congenital heart defects	T019	C0018798
28424445	249	265	pregnant females	T098	C0033011
28424445	267	275	Presence	T033	C0150312
28424445	279	294	tachyarrhythmia	T033	C0080203
28424445	302	311	pregnancy	T040	C0032961
28424445	318	322	risk	T078	C0035647
28424445	330	336	mother	T099	C0026591
28424445	341	346	fetus	T018	C0015965
28424445	348	355	calling	T041	C0679006
28424445	360	376	proper treatment	T061	C0087111
28424445	382	393	medications	T121	C0013227
28424445	402	422	antiarrhythmic drugs	T121	C0003195
28424445	435	443	maternal	T033	C1858460
28424445	444	459	tachyarrhythmia	T033	C0080203
28424445	474	487	consideration	T078	C0750591
28424445	491	500	potential	T080	C3245505
28424445	501	525	teratogenic side effects	T046	C0232910
28424445	527	538	Utilization	T169	C0042153
28424445	542	562	antiarrhythmic drugs	T121	C0003195
28424445	570	579	pregnancy	T040	C0032961
28424445	594	601	studied	T062	C2603343
28424445	608	614	result	T169	C1274040
28424445	618	625	minimal	T080	C0547040
28424445	626	631	fetal	T018	C0015965
28424445	632	636	harm	T037	C0005604
28424445	657	667	techniques	T169	C0449851
28424445	677	693	cardiac ablation	T061	C0162563
28424445	710	721	implemented	T052	C1708476
28424445	727	734	minimal	T080	C0547040
28424445	741	759	radiation exposure	T037	C0015333
28424445	767	772	fetus	T018	C0015965
28424445	776	782	mother	T099	C0026591
28424445	784	798	Pregnant women	T098	C0033011
28424445	804	819	tachyarrhythmia	T033	C0080203
28424445	830	842	successfully	T080	C1272703
28424445	843	850	treated	T033	C0332154
28424445	856	862	little	T081	C0700321
28424445	869	875	impact	T080	C4049986
28424445	883	899	developing fetus	T039	C3824789
28424445	903	909	result	T169	C1274040
28424445	913	923	increasing	T169	C0442808
28424445	924	934	experience	T041	C0596545
28424445	940	960	antiarrhythmic drugs	T121	C0003195
28424445	965	973	progress	T169	C1280477
28424445	981	991	procedural	T169	C2700391
28424445	992	1002	techniques	T169	C0449851